• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Wednesday 11/14/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

CBD business

  • 2:48 PM

    LAS VEGAS, Sept. 29, 2016, MEDT, /PRNewswire/ – MEDIATECHNICS CORPORATION (OTC: MEDT) is pleased to announce that it has entered into a letter of intent (LOI) with Vaxa Industries of Denver, Colorado (VAXA) to market CBD base hemp products on a wholesale basis. VAXA will supply MEDT with high purity CBD isolates on a wholesale basis at less than one third of the average wholesale price. Multiple sources currently sell, on a wholesale basis, CBD for as much as $30-50,000

    Read more
  • 6:02 PM

    Issued Patent Strengthens Magnolia’s IP Position in the Field of Flexible PhotovoltaicsALBANY, N.Y., Nov 25, 2014 (GLOBE NEWSWIRE via COMTEX) — Magnolia Solar Corporation (OTCQB:MGLT) (“Magnolia Solar”) announced today that its wholly owned subsidiary, Magnolia Solar, Inc., was recently issued a patent by the United States Patent and Trademark Office (USPTO). Magnolia Solar, Inc. is the assignee of US Patent No. 8,865,506 which describes a roll-to-roll process method for fabricating solar cells. The patent issued on October 21, 2014 and

    Read more
  • 4:15 PM

    ALAMEDA, Calif., Jul 16, 2014 (BUSINESS WIRE) — InSite Vision Incorporated (OTCBB:INSV) today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent No. 8,778,999 covering Bromfenac Non-Steroidal Ophthalmic Compositions Formulated in DuraSite. The allowed patent contains both composition and method of treatment claims that will broadly cover all of InSite’s bromfenac product candidates, including BromSite(TM) (bromfenac 0.075% ophthalmic solution formulated in DuraSite, ISV-303) for the treatment of inflammation and prevention of pain post cataract

    Read more
Public Wire Banner